Skip to main content
Skip to footer
The ACTC repository is under review for potential modification in compliance with Administration directives.
Follow us on:
Podcast
Apple Podcast
Spotify
Amazon Music and Audible
About
Mission and Vision
ATRI Leadership
Timeline
Careers
Research
Clinical Trials
Groups
Studies
Site Locations
Participate
Basic Science
Education
Student Summer Research Program
People
Our People
Leadership & Faculty
Team Leads
Teams
Resources
News
Events Calendar
Resource Library
Take Action
Enrollment Status:
Actively Enrolling
APEX Study
May 2, 2024
The Alzheimer’s Plasma Extension (APEX) Study is a multicenter, observational study on Alzheimer’s disease (AD) related brain changes being conducted…
Trial-Ready Cohort- Down Syndrome (TRC-DS)
February 24, 2022
The Trial-Ready Cohort- Down Syndrome (TRC-DS) aims to enroll 450 non-demented adults (ages 25-55) with Down syndrome (DS) into a…
Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS)
February 24, 2022
The LEADS study – or the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) explores the development of early-onset Alzheimer’s disease and…
Alzheimer Prevention Trials (APT) Webstudy
February 24, 2022
If you are 50 years of age or older, you can monitor your own cognitive health by participating in the…
Synaptic Therapy Alzheimer’s Research Trial
February 24, 2021
This study is investigating whether CT1812, a novel and promising therapeutic candidate can halt or slow the process of Alzheimer’s…
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
February 24, 2021
The Alzheimer’s Disease Neuroimaging Initiative (ADNI), a landmark study that began in 2004, is a public-private research partnership tasked with…
Life’s End Benefits of Cannabidiol and Tetrahydrocannabinol (LiBBY)
March 24, 2020
Approximately fifty percent of people diagnosed with Alzheimer’s disease or other types of dementia will receive hospice care at the…